Patients carrying CYP2C8*3 have shorter systemic paclitaxel exposure
{{output}}
Aim: First, evaluate if patients carrying putatively diminished activity CYP2C8 genotype have longer paclitaxel exposure (e.g., time above threshold concentration of 0.05 μM [Tc >0.05]). Second, screen additional pharmacogenes f... ...
